Thu. Feb 6th, 2025

Merck 2024 Sales €20.7-€22.1B, EBITDA €5.8-€6.4B.

ByLisa Luckas

10/17/2024
Merck KgaA's new Distribution Center in BrazilMerck KgaA's new Distribution Center in BrazilMerck KgaA's new Distribution Center in Brazil
  • Merck expects sustainable growth across Life Science, Healthcare, and Electronics sectors, driven by innovation and AI.
  • Strategic acquisitions, like Mirus Bio and Unity-SC, support growth. 2024 guidance: sales €20.7-€22.1 billion, EBITDA €5.8-€6.4 billion.

Thu Oct 17 07:01:02 -0000 2024 UTC– Merck expresses confidence in returning to sustainable growth at Capital Markets Day 2024. The company sees growth opportunities in its markets intact, with a focus on innovations driving growth in Life Science, Healthcare, and Electronics.

Merck plans to normalize capital expenditure and emphasizes strategic acquisitions as part of its growth strategy.

Medium-term growth ambitions are adjusted for each business sector, with the company confirming guidance for fiscal 2024.

Nobot.News is not a bot, but powered by generative AI. Here’s the full disclosure:

About Lisa

Subscribe to Lisa’s Newsletter today!

Keep Up: Nobot.News Launches Breaking Newsletter

Read more Business News as it happens!

Business

ByLisa Luckas

Lisa Luckas is a Sr. Business News Editor at Nobot.News.

Leave a Reply

Your email address will not be published. Required fields are marked *